Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
SiriusPoint
SPNT
$2.68B
| $24K | ﹤0.01% |
1,707
-2,574
| -60% | -$35.7K |
|
5577
CALL
Direxion Daily Technology Bear 3x ETF
TECS
$55.6M
| – | – |
0
| – | – |
|
5578
Tompkins Financial
TMP
$1.42B
| $24K | ﹤0.01% |
445
-762
| -63% | -$40.1K |
|
5579
Tempest Therapeutics
TPST
$14.6M
| – | – |
-1
| Closed | -$133K |
|
|
VIVO
5580
DELISTED
Meridian Bioscience Inc
VIVO
| $24K | ﹤0.01% |
1,248
-3,693
| -75% | -$68.3K |
|
|
MANT
5581
DELISTED
Mantech International Corp
MANT
| $24K | ﹤0.01% |
718
-806
| -53% | -$26.4K |
|
|
GLOG
5582
DELISTED
GASLOG LTD
GLOG
| $24K | ﹤0.01% |
1,264
-1,134
| -47% | -$21.3K |
|
|
PE
5583
DELISTED
PARSLEY ENERGY INC
PE
| $24K | ﹤0.01% |
1,596
-1,480
| -48% | -$23.1K |
|
|
SCLN
5584
CALL
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $24K | ﹤0.01% |
+3,000
| New | +$23.9K |
|
5585
Arrowhead Research
ARWR
$12.4B
| $23K | ﹤0.01% |
3,673
-969
| -21% | -$6.88K |
|
5586
City Holding Co
CHCO
$2.04B
| $23K | ﹤0.01% |
471
-804
| -63% | -$36.4K |
|
5587
Cohen & Steers
CNS
$4.3B
| $23K | ﹤0.01% |
583
-990
| -63% | -$42.2K |
|
5588
CALL
Dolby
DLB
$5.79B
| $23K | ﹤0.01% |
600
-2,200
| -79% | -$87.8K |
|
|
DOG
5589
PUT
ProShares Short Dow30
DOG
$97.3M
| $23K | ﹤0.01% |
+250
| New | +$23.2K |
|
5590
Flotek Industries
FTK
$1.28B
| $23K | ﹤0.01% |
269
-7,434
| -97% | -$727K |
|
5591
CALL
Cedar Fair
FUN
$1.67B
| $23K | ﹤0.01% |
400
+100
| +33% | +$5.41K |
|
5592
PUT
IMAX
IMAX
$2.66B
| $23K | ﹤0.01% |
700
-44,800
| -98% | -$1.49M |
|
5593
PUT
Ingredion
INGR
$6.58B
| $23K | ﹤0.01% |
300
-2,100
| -88% | -$172K |
|
5594
Materion
MTRN
$6.04B
| $23K | ﹤0.01% |
619
-1,054
| -63% | -$37.9K |
|
|
PDS
5595
PUT
Precision Drilling
PDS
$974M
| $23K | ﹤0.01% |
190
+95
| +100% | +$10.9K |
|
5596
Safety Insurance
SAFT
$1.52B
| $23K | ﹤0.01% |
390
-348
| -47% | -$21.3K |
|
5597
Shenandoah Telecom
SHEN
$746M
| $23K | ﹤0.01% |
1,448
-6,186
| -81% | -$94.5K |
|
5598
Team
TISI
$77.7M
| $23K | ﹤0.01% |
61
-105
| -63% | -$40.3K |
|
5599
Uranium Energy
UEC
$5.57B
| $23K | ﹤0.01% |
22,921
-14,425
| -39% | -$20.5K |
|
|
UMH
5600
UMH Properties
UMH
$1.36B
| $23K | ﹤0.01% |
2,207
+1,027
| +87% | +$9.93K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.